AN EVALUATION OF EGG SHELL DERIVED HYDROXYAPATITE AS BONE GRAFT MATERIAL IN THE HEALING OF BONE DEFECTS

Eggshell-derived hydroxyapatite becomes a viable choice as regenerative material because of its biocompatibility, lack of disease transfer risks, ease of use, and unlimited availability of eggshell raw material. The grafting prevented dead space and undue complications associated with a large hematoma in the surgical defect. The EHA acts as a space filler and osteoconductive economic graft material. It is a versatile biocompatible graft substitute that does not cause any chronic inflammatory, allergic, or toxic reactions.